EDGAR Filing Documents for 0001193125-12-191724

Form 8-K - Current report:

SEC Accession No. 0001193125-12-191724

Filing Date

2012-04-27

Accepted

2012-04-27 17:23:48

Documents

Period of Report

2012-04-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d341488d8k.htm	8-K	28710
2	AGREEMENT AND PLAN OF MERGER	d341488dex21.htm	EX-2.1	510182
3	PRESS RELEASE	d341488dex991.htm	EX-99.1	34931
4	TRANSCRIPT	d341488dex992.htm	EX-99.2	1703
5	GRAPHIC	g341488g45y48.jpg	GRAPHIC	12130
6	GRAPHIC	g341488g68h97.jpg	GRAPHIC	12176
	Complete submission text file	0001193125-12-191724.txt		610592

Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2

Business Address 45 FITZWILLIAM SQUARE DUBLIN L2 2 353-1-634-4183

Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)